Reig Jofre, a pharma company listed on the Spanish stock market, has acquired Bioiberica’s portfolio of specialized joint health finished pharmaceutical products and nutraceuticals for the treatment of arthrosis and other arthropathies. It is also expanding its product portfolio with medicines and health products based on chondroitin sulfate, glucosamine sulfate, the combination of both and hyaluronic acid, among which are leading brands in the Spanish market and widely-known by prescribers and patients, and which enjoy a strong presence in European markets such as France, Finland and Portugal.